Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Erik D. Roberson,1,2*Kimberly Scearce-Levie,1,2Jorge J. Palop,1,2Fengrong Yan,1Irene H. Cheng,1,2Tiffany Wu,1Hilary Gerstein,1Gui-Qiu Yu,1Lennart Mucke1,2*
Many potential treatments for Alzheimer's disease target amyloid-ßpeptides (Aß), which are widely presumed to causethe disease. The microtubule-associated protein tau is alsoinvolved in the disease, but it is unclear whether treatmentsaimed at tau could block Aß-induced cognitive impairments.Here, we found that reducing endogenous tau levels preventedbehavioral deficits in transgenic mice expressing human amyloidprecursor protein, without altering their high Aßlevels. Tau reduction also protected both transgenic and nontransgenicmice against excitotoxicity. Thus, tau reduction can block Aß-and excitotoxin-induced neuronal dysfunction and may representan effective strategy for treating Alzheimer's disease and relatedconditions.
1 Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA. 2 Department of Neurology, University of California, San Francisco, CA 94158, USA.
* To whom correspondence should be addressed. E-mail: eroberson{at}gladstone.ucsf.edu (E.D.R.); lmucke{at}gladstone.ucsf.edu (L.M.)
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Stella M. Hurtley (8 May 2007) Sci. STKE2007 (385), tw163.
[DOI: 10.1126/stke.3852007tw163] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Continuous CSF drainage in AD: Results of a double-blind, randomized, placebo-controlled study.
G. D. Silverberg, M. Mayo, T. Saul, J. Fellmann, J. Carvalho, and D. McGuire (2008)
Neurology
71, 202-209
|Abstract »|Full Text »|PDF »
Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase C{gamma}1, Grb2, and Src Family Kinases.
C. H. Reynolds, C. J. Garwood, S. Wray, C. Price, S. Kellie, T. Perera, M. Zvelebil, A. Yang, P. W. Sheppard, I. M. Varndell, et al. (2008)
J. Biol. Chem.
283, 18177-18186
|Abstract »|Full Text »|PDF »
Distinct mechanisms of impairment in cognitive ageing and Alzheimer's disease.
Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease Synaptosomes.
J. A. Fein, S. Sokolow, C. A. Miller, H. V. Vinters, F. Yang, G. M. Cole, and K. H. Gylys (2008)
Am. J. Pathol.
172, 1683-1692
|Abstract »|Full Text »|PDF »
Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease.
W. J. Meilandt, G.-Q. Yu, J. Chin, E. D. Roberson, J. J. Palop, T. Wu, K. Scearce-Levie, and L. Mucke (2008)
J. Neurosci.
28, 5007-5017
|Abstract »|Full Text »|PDF »
A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease.
Y. Matsuoka, Y. Jouroukhin, A. J. Gray, L. Ma, C. Hirata-Fukae, H.-F. Li, L. Feng, L. Lecanu, B. R. Walker, E. Planel, et al. (2008)
J. Pharmacol. Exp. Ther.
325, 146-153
|Abstract »|Full Text »|PDF »
Cyclooxygenase-2 inhibition improves amyloid-{beta}-mediated suppression of memory and synaptic plasticity.
L. A. Kotilinek, M. A. Westerman, Q. Wang, K. Panizzon, G. P. Lim, A. Simonyi, S. Lesne, A. Falinska, L. H. Younkin, S. G. Younkin, et al. (2008)
Brain
131, 651-664
|Abstract »|Full Text »|PDF »
The Potential for -Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy.
M.-M. Mocanu, A. Nissen, K. Eckermann, I. Khlistunova, J. Biernat, D. Drexler, O. Petrova, K. Schonig, H. Bujard, E. Mandelkow, et al. (2008)
J. Neurosci.
28, 737-748
|Abstract »|Full Text »|PDF »
The beta-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy.
K. Eckermann, M.-M. Mocanu, I. Khlistunova, J. Biernat, A. Nissen, A. Hofmann, K. Schonig, H. Bujard, A. Haemisch, E. Mandelkow, et al. (2007)
J. Biol. Chem.
282, 31755-31765
|Abstract »|Full Text »|PDF »
A Tale about Tau.
K. H. Ashe (2007)
N. Engl. J. Med.
357, 933-935
|Full Text »|PDF »
